TXMD

Q: What is the price of TherapeuticsMD (TXMD) today?

The current price of TherapeuticsMD (TXMD) is $1.95. The stock began the year trading around $1.63 and is currently priced at $1.95. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does TherapeuticsMD (TXMD) pay dividends?

TherapeuticsMD (TXMD) did not pay dividends over the past year.

Q: Is TherapeuticsMD (TXMD) a good investment?

TherapeuticsMD (TXMD) is currently trading at $1.95 with a P/E ratio of 130.00. This represents a 1,757% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 78.90%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

TherapeuticsMD Inc.

Price

$1.95

return (12m)

78.90%

p/e

130.00

p/bv

0.87

DIVIDEND YIELD

0.00%

TXMD price

TherapeuticsMD

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TXMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.02%

3 months

-15.58%

1 year

78.90%

2 years

1.56%

5 years

-96.75%

10 years

-99.53%

Fundamentals TXMD

review the fundamentals of TherapeuticsMD shares

P/E

130.00

Sector: -2.09 Industry: -5.41

P/S (PSR)

7.01

Sector: 1.96 Industry: 3.06

P/BV

0.87

Sector: 2.11 Industry: 1.91

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.48%

Sector: -27.28% Industry: -48.67%

ROE

0.67%

Sector: -32.48% Industry: -44.90%

ROIC

-10.16%

Sector: -444.34% Industry: -542.40%

NET MARGIN

5.39%

Sector: -29.63% Industry: -36.04%

GROSS MARGIN

100.00%

Sector: 44.85% Industry: 48.01%

OPERATING MARGIN

-100.00%

Sector: -24.54% Industry: -31.89%

EV/EBITDA

-7.60

Sector: -0.22 Industry: -3.07

EV/EBIT

-5.48

Sector: -1.81 Industry: -5.09

PRICE-TO-ASSETS

0.62

Sector: 1.17 Industry: 1.28

BVPS

2.25

Sector: 3.85 Industry: 2.07

EPS

0.02

Sector: -0.89 Industry: -1.24

EQUITY-TO-ASSETS RATIO

0.72

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.28

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

5.30%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF TherapeuticsMD ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$1.95

Fair Value

$1.01

Upside Return potential.

-48.40%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TXMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.90	31.52	81.02%	0.59%	$983.22 B	34.99%
ISRG	48.47	8.21	16.93%	0.00%	$144.41 B	28.15%
SNY	6.93	1.23	17.79%	4.17%	$103.45 B	14.75%
TMO	25.24	3.32	13.15%	0.38%	$172.83 B	15.15%
NVS	20.75	7.21	34.77%	2.11%	$280.79 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$149.12 B	13.91%
MDT	21.17	2.03	9.59%	3.58%	$101.63 B	13.20%
GSK	12.88	4.35	33.77%	3.49%	$101.09 B	17.79%
CVS	42.69	1.61	3.78%	2.71%	$125.16 B	0.72%
BSX	18.99	2.62	13.78%	0.00%	$67.71 B	17.29%
TMDX	15.58	5.42	34.80%	0.00%	$2.68 B	27.04%
IDXX	41.06	28.90	70.38%	0.00%	$44.97 B	24.63%
HCA	12.37	-28.22	-228.14%	0.78%	$84.04 B	8.89%
RMD	18.00	4.21	23.41%	1.27%	$27.35 B	27.44%
DHR	34.00	2.37	6.97%	0.77%	$125.44 B	14.89%
INMD	9.68	1.28	13.18%	0.00%	$844.20 M	23.27%
PHG	22.56	1.93	8.56%	3.78%	$25.49 B	5.50%
SYK	35.23	5.12	14.52%	1.12%	$117.55 B	13.21%
CI	11.36	1.75	15.39%	2.20%	$73.79 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TXMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/06/2008	06/10/2008	666.66666600

ABOUT TherapeuticsMD

TherapeuticsMD Inc.

Average Investor10 user rating

4.0 (0 people)

United States

119 years

Founded: 1907

2007

Time since IPO - 19 years

400

Employees

TherapeuticsMD Inc. (United States) is listed on the Nasdaq and has a market capitalization of $23.40 million, with shareholders equity totaling $26.97 million.

The company employs approximately 400 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, TherapeuticsMD Inc. reported $3.34 million in revenue, generating net income of $180.00 Thousand.

Key financial metrics include a P/E ratio of 130.00, a price-to-book (P/B) ratio of 0.87, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TXMD.

Market cap

$23.40 million

Net worth

$26.97 million

$26,970,000.00

Assets

$37.58 million

$37,580,000.00

Total Shares Outstanding

12.00 million

12,000,000

Average Daily Trading Volume

$39.59 Thousand

$39,590.00

Sector

Health

Industry

Pharmaceutical Products

TXMD

TXMD revenue and profits

Financial Results TXMD

DRAG THE FRAME TO SEE MORE DATA

TXMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$98.32 53,08% (12M)

P/E

42.69

2.71%

ROE

3.78%

P/BV

1.61

CI - Cigna

$279.27 --9,20% (12M)

P/E

11.36

2.20%

ROE

15.39%

P/BV

1.75

CNC - Centene

$61.02 12,17% (12M)

P/E

-4.66

0.00%

ROE

-29.93%

P/BV

1.39

HUM - Humana

$360.65 53,26% (12M)

P/E

38.30

0.98%

ROE

6.06%

P/BV

2.32

SNY - Sanofi

$42.38 --7,96% (12M)

P/E

6.93

4.17%

ROE

17.79%

P/BV

1.23

LLY - Eli Lilly

$1,098.57 43,57% (12M)

P/E

38.90

0.59%

ROE

81.02%

P/BV

31.52

HCA - HCA Healthcare

$375.17 0,23% (12M)

P/E

12.37

0.78%

ROE

-228.14%

P/BV

-28.22

NVS - Novartis

$147.09 29,52% (12M)

P/E

20.75

2.11%

ROE

34.77%

P/BV

7.21

CVS - CVS Health

$98.32 53,08% (12 M)

P/L

42.69

2.71%

ROE

3.78%

P/VP

1.61

CI - Cigna

$279.27 --9,20% (12 M)

P/L

11.36

2.20%

ROE

15.39%

P/VP

1.75

CNC - Centene

$61.02 12,17% (12 M)

P/L

-4.66

0.00%

ROE

-29.93%

P/VP

1.39

HUM - Humana

$360.65 53,26% (12 M)

P/L

38.30

0.98%

ROE

6.06%

P/VP

2.32

SNY - Sanofi

$42.38 --7,96% (12 M)

P/L

6.93

4.17%

ROE

17.79%

P/VP

1.23

LLY - Eli Lilly

$1,098.57 43,57% (12 M)

P/L

38.90

0.59%

ROE

81.02%

P/VP

31.52

HCA - HCA Healthcare

$375.17 0,23% (12 M)

P/L

12.37

0.78%

ROE

-228.14%

P/VP

-28.22

NVS - Novartis

$147.09 29,52% (12 M)

P/L

20.75

2.11%

ROE

34.77%

P/VP

7.21

Frequently Asked Questions

What is the price of TherapeuticsMD (TXMD) today?

The current price of TherapeuticsMD (TXMD) is $1.95. The stock began the year trading around $1.63 and is currently priced at $1.95. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does TherapeuticsMD (TXMD) pay dividends?

TherapeuticsMD (TXMD) did not pay dividends over the past year.

Is TherapeuticsMD (TXMD) a good investment?

TherapeuticsMD (TXMD) is currently trading at $1.95 with a P/E ratio of 130.00. This represents a 1,757% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 78.90%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy TherapeuticsMD (TXMD) stock?

You can buy TherapeuticsMD (TXMD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol TXMD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of TherapeuticsMD (TXMD) yield today?

Over the past month, TherapeuticsMD (TXMD) has returned -8.02% — 78.90% over the past year, and -96.75% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of TherapeuticsMD (TXMD) today at the current price of $1.95 your total investment would be $195.00.

Based on historical performance, the investment would have grown to approximately:

$348.86 after 1 year
$6.34 after 5 years
$0.92 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

TXMD

TherapeuticsMD Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment TXMD

review the fundamentals of TherapeuticsMD shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT TherapeuticsMD

TherapeuticsMD Inc.

United States

119 years

2007

400

PROFIT X PRICE TXMD

Financial Results TXMD

TXMD cash flow

Asset, Revenue and Profit Growth - TXMD

TXMD balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions